| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |